Back
OrthoPediatrics 10K Form
Buy
52
KIDS
OrthoPediatrics
Last Price:
28.00
Seasonality Move:
3.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-06 | 10Q | KIDS/OrthoPediatrics Quarterly |
2020-05-06 | 10Q | KIDS/OrthoPediatrics Quarterly |
2020-03-05 | 10K | KIDS/OrthoPediatrics Annual |
2019-11-08 | 10Q | KIDS/OrthoPediatrics Quarterly |
2019-08-13 | 10Q | KIDS/OrthoPediatrics Quarterly |
2019-05-09 | 10Q | KIDS/OrthoPediatrics Quarterly |
Receive KIDS News And Ratings
See the #1 stock for the next 7 days that we like better than KIDS
KIDS Financial Statistics
Sales & Book Value
Annual Sales: | $148.73M |
---|---|
Cash Flow: | $-12.78M |
Price / Cash Flow: | 0 |
Annual Sales: | $15.33 |
Price / Book: | 1.78 |
Profitability
EPS (TTM): | -1.09000 |
---|---|
Net Income (TTM): | $-25.12M |
Gross Margin: | $111.25M |
Return on Equity: | -6.7% |
Return on Assets: | -5.78% |
OrthoPediatrics Earnings Forecast
Key OrthoPediatrics Financial Ratios
- The Gross Profit Margin over the past 10 years for KIDS is 74.80%.
- The Selling, General & Administrative Expenses for KIDS have been equal to 85.27% of Gross Profit Margin.
- The Research & Development expenses have been 6.86% of Revenue.
- The Interest Expense is 192.69% of Operating Income.
- The Net Earning history of KIDS is -14.10% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 6 years.
OrthoPediatrics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | KIDS |
CUSIP: | 68752L |
Website: | orthopediatrics.com |
Debt
Debt-to-Equity Ratio: | 0.03 |
---|---|
Current Ratio: | 4.9 |
Quick Ratio: | 1.79 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
KIDS Technical Analysis vs Fundamental Analysis
Buy
52
OrthoPediatrics (KIDS)
is a Buy
Is OrthoPediatrics a Buy or a Sell?
-
OrthoPediatrics stock is rated a Buy
The current OrthoPediatrics [KIDS] share price is $27.36. The Score for KIDS is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.